Beauty Health (SKIN): Debts to Book Capitalization

Corporate company logo of Beauty Health (SKIN)

The Beauty Health (SKIN) generates revenue through the supply of HydraFacial systems, combining hardware sales with the recurring distribution of high-margin consumables. The business leverages the growth of beauty-tech by implementing digital dermal analysis methods and smart hydradermabrasion. The current metric stands at 6.67. The historical price action shown below reflects quotes amid general retail sector saturation and stable demand for specialized serums.

Debt to Book Capital: The Beauty Health Company (SKIN) for 07/04/2022 - 10/28/2026
Flagship merchandise of BeautyHealth

Stabilization of management and optimization of HydraFacial inventories allow The Beauty Health (SKIN) to more effectively control its liability structure, as reflected by the ratio of financial debt to book capitalization. This coefficient compares total borrowings with equity, demonstrating the business's degree of dependence on creditors; a decrease in this metric confirms growing financial stability and a reduction in default risks amid the current management restructuring.

Competitors of The Beauty Health (SKIN)

HCA: Debts to Book Capitalization|Debts to Book Value tenethealth.com THC|Fresenius Medical Care AG & Co. KGaA - Debts to Book Capitalization|Solventum Corp (SOLV) - Debts to Book Capitalization|EHC - Debt to Book Value|UHS (Universal Health Services, Inc.) - Debt to Book Capital|Debt to Book Capitalization Ratio DVA|Debt to Book Value radnet.com|Option Care Health, Inc. - Debts to Book Capitalization|Debts to Book Value SGRY (Surgery Partners Inc)|PINC - Debt to Book Capitalization Ratio|EYE - Debt to Book Value Ratio|Debt to Book Value Progyny, Inc. PGNY|ardenthealth.com (ARDT) - Debt to Book Capital|SEM - Debt to Book Value|Astrana Health Inc (ASTH) - Debt to Book Capital|MD - Debts to Book Capitalization|Debt to Net Assets Ratio US Physical Therapy Inc|The Pennant Group, Inc. - Debts to Book Capitalization|Debts to Book Value organogenesis.com ORGO|Debt to Book Value Nutex Health|Debt to Net Assets Ratio Auna S.A. AUNA|SBC - Debts to Book Capitalization|EOLS - Debt to Book Capitalization Ratio|Debts to Book Capitalization CYH|MediWound (MDWD) - Debts to Book Value|BTMD (biote Corp) - Debts to Book Capitalization|Debts to Book Capitalization The Joint Corp (JYNT)|Debt to Book Value DCGO|Debts to Book Capitalization p3hp.org PIII|Debt to Book Value Gain Therapeutics (GANX)|EUDA - Debt to Book Capital|BMGL (Basel Medical Group Limited) - Debt to Book Value|CollPlant Biotechnologies (CLGN) - Debts to Book Value|Debt to Book Value Cuprina Holdings Ltd CUPR|Concord Medical Corp (CCM) - Debt to Net Assets Ratio|AMS - Debts to Book Capitalization|Debt to Net Assets Ratio medirom.co.jp|Avalon GloboCare - Debts to Book Capitalization|Debts to Book Value DIH Holding US (DHAI)|Debts to Book Capitalization XAGE (Longevity Health Holdings Inc)|NewGenIvf Corp - Debts to Book Capitalization|ATIP - Debt to Book Capitalization Ratio|caremax.com (CMAX) - Debt to Book Capitalization Ratio|KDLY - Debt to Book Value|ModivCare Inc (MODV) - Debt to Book Capital|NVOS - Debts to Book Capitalization|Debt to Net Assets Ratio SSY|BACK (IMAC Holdings, Inc.) - Debt to Book Capitalization Ratio